Final results from a pivotal phase 3 malaria vaccine trial

The Lancet

Volumn 386, Issue 9988, 2015, Pages 5-7

  Moorthy, Vasee S ^a   Okwo Bele, Jean Marie ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA VACCINE; RTS,S VACCINE; UNCLASSIFIED DRUG;

CLINICAL EFFECTIVENESS; HUMAN; INFECTION PREVENTION; INFECTION RISK; MALARIA; MALARIA CONTROL; NOTE; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; VACCINATION; FEMALE; MALARIA, FALCIPARUM; MALE;

FEMALE; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; MALE;

EID: 84937526820     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60767-X     Document Type: Note

References (5)

1. RTS,S Clinical Trials Partnership Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial Lancet 2015 published online April 24. http://dx.doi.org/10.1016/S0140-6736(15)60721-8
2. RTS,S Clinical Trials Partnership First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children N Engl J Med 365 2011 1863 1875
3. RTS,S Clinical Trials Partnership A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants N Engl J Med 367 2012 2284 2295
4. RTS,S Clinical Trials Partnership Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites PLoS Med 11 2014 e1001685
5. WHO World malaria report 2014 2014 World Health Organization Geneva http://who.int/malaria/publications/world-malaria-report-2014/en/ (accessed April 16, 2015).